Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for reducing dependence and craving in amphetamine and methamphetamine users
IRCT20230606058397N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of mirtazapine in methamphetamine use disorder (MUD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Reduction in dependence on amphetamine/methamphetamine and Reduction in craving/temptation to consume amphetamine/methamphetamine. Started Sep 2023; status: completed.
02
Drugs
mirtazapine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on IRCT20230606058397N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230606058397N1.